Diffuse pulmonary infiltrates after bone marrow transplantation: The role of open lung biopsy

Annals of Thoracic Surgery

Volumn 78, Issue 1, 2004, Pages 267-272

  Wang, Jann Yuan ^b   Chang, Yih Leong ^b   Lee, Li Na ^b   Chen, Jen Hau ^b   Tang, Jih Luh ^b   Yang, Pan Chyr ^b   Lee, Yung Chie ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

11

Indexed keywords

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HEPATITIS; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL PNEUMONIA; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MILIARY TUBERCULOSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPEN LUNG BIOPSY; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; RECIPIENT; RESPIRATORY FAILURE; REVIEW;

EID: 3042621039     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.03.002     Document Type: Article

References (39)

1. O'Reilly R.J. Allogeneic bone marrow transplantation current status and future directions. Blood. 62:1983;941-944
2. Soubani A.O., Miller K.B., Hassoun P.M. Pulmonary complications of bone morrow transplantation. Chest. 109:1996;1066-1077
3. Gentile G., Micozzi A., Girmenia C., et al. Pneumonia in allogenic and autologous bone marrow recipients. A retrospective study. Chest. 104:1993;371-375
4. Prober C.G., Whyte H., Smith C.R. Open lung biopsy in immunocompromised children with pulmonary infiltrates. Am J Dis Child. 138:1984;60-63
5. McKenna R.J. Jr, Mountain C.F., McMurtrey M.J. Open lung biopsy in immunocompromised patients. Chest. 86:1984;671-674
6. Haverkos H.W., Dowling J.N., Pasculle A.W., Myerowitz R.L., Lerberg D.B., Hakala T.R. Diagnosis of pneumonitis in immunocompromised patients by open lung biopsy. Cancer. 52:1983;1093-1097
7. Crawford S.W., Hackman R.C., Clark J.G. Open lung biopsy diagnosis of diffuse pulmonary infiltrates after marrow transplantation. Chest. 94:1988;949-953
8. Poe R.H., Wahl G.W., Qazi R., Kallay M.C., Utell M.J., Morrow G.R. Predictors of mortality in the immunocompromised patient with pulmonary infiltrates. Arch Intern Med. 146:1986;1304-1308
9. Rano A., Agusti C., Benito N., et al. Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates. Chest. 122:2002;253-261
10. Agusti C., Rano A., Filella X., et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment. Chest. 123:2003;488-498
11. Hayes-Jordan A., Benaim E., Richardson S., et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg. 37:2002;446-452
12. Mori T., Okamoto S., Matsuoka S., et al. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant. 25:2000;765-769
13. Machado C.M., Menezes R.X., Macedo M.C., et al. Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT. Bone Marrow Transplant. 28:2001;1053-1059
14. Kurihara T., Hayashi J., Ito A., Asai T. CMV antigenemia assay using indirect ALP-immunostaining in bone marrow transplant recipients. Transplant Proc. 28:1996;1750-1753
15. Wingard J.R., Mellits E.D., Sostrin M.B., et al. Interstitial pneumonitis after allogeneic bone marrow transplantation. Medicine. 67:1988;175-186
16. Atkinson K., Nivison-Smith I., Dodds A., Concannon A., Milliken S., Downs K. A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989. Bone Marrow Transplant. 21:1998;691-695
17. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., Sibbald W.J. Multiple organ dysfunction score a reliable predictor of a complex clinical outcome. Crit Care Med. 23:1995;1638-1652
18. Ewig S., Schafer H., Torres A. Severity assessment in community-acquired pneumonia. Eur Respir J. 16:2000;1193-1201
19. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 15:1995;825-828
20. Dunagan D.P., Baker A.M., Hurd D.D., Haponik E.F. Bronchoscopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest. 111:1997;135-141
21. Gruson D., Hilbert G., Valentino R., et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med. 28:2000;2224-2230
22. Rano A., Agusti C., Jimenez P., et al. Pulmonary infiltrates in non-HIV immunocompromised patients a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax. 56:2001;379-387
23. Feinstein M.B., Mokhtari M., Ferreiro R., Stover D.E., Jakubowski A. Fiberoptic bronchoscopy in allogeneic bone marrow transplantation findings in the era of serum cytomegalovirus antigen surveillance. Chest. 120:2001;1094-1100
24. Murray P.V., O'Brien M.E., Padhani A.R., et al. Infection post transplant use of first line bronchoalveolar lavage in the immunosuppressed oncology patient. Bone Marrow Transplant. 27:2001;967-971
25. Stover D.E., Zaman M.B., Hajdu S.I., Lange M., Gold J., Armstrong D. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med. 101:1984;1-7
26. Von Eiff M., Zuhlsdorf M., Roos N., Hesse M., Schulten R., van de Loo J. Pulmonary fungal infections in patients with haematological malignancies - diagnostic approaches. Ann Haematol. 70:1995;135-141
27. Campbell J.H., Blessing N., Burnett A.K., Stevenson R.D. Investigation and management of pulmonary infiltrates following bone marrow transplantation an eight year review. Thorax. 48:1993;1248-1251
28. Chandrasekar P.H., Weinmann A., Shearer C. Autopsy-identified infections among bone marrow transplant recipients a clinico-pathologic study of 56 patients. Bone Marrow Transplantation Team. Bone Marrow Transplant. 16:1995;675-681
29. Conti D.J., Freed B.M., Singh T.P., Gallichio M., Gruber S.A., Lempert N. Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients. Arch Surg. 130:1995;1217-1221
30. Hibberd P.L., Tolkoff Rubin N.E., Conti D., et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients a randomized controlled trial. Ann Intern Med. 123:1995;18-26
31. Fox B.C., Sollinger H.W., Belzer F.O., Maki D.G. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med. 89:1990;255-274
32. White P. Evaluation of pulmonary infiltrates in critically ill patients with cancer and marrow transplant. Crit Care Clin. 17:2001;647-670
33. Jordan M.C. Cytomegalovirus infections. Hoeprich P.D., Jordan M.C., Ronald A.R. Infectious disease a treatise of infectious processes. 1994;835-840 Lippincott, Philadelphia
34. Bureau for Chronic Disease Control. TB statistics (Taiwan) - 1999. [in Chinese]:2001;Bureau for Chronic Disease Control, Taipei, Taiwan. 8-17
35. Weisdorf D.J., McGlave P.B., Ramsay N.K., et al. Allogeneic bone marrow transplantation for acute leukemia comparative outcome for adults and children. Br J Haematol. 69:1988;351-358
36. Winston D.J., Ho W.G., Ghamplin R.E. Cytomegalovirus infections after allogeneic bone marrow transplantation. Rev Infect Dis. 12:(Suppl 7):1990;S776-792
37. Broers A.E., van Der Holt R., van Esser J.W., et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood. 95:2000;2240-2245
38. Bostrom L., Ringden O., Gratama J.W., Jacobsen N., Zwaan F., Nilsson B. The impact of pre-transplant herpes virus serology on acute and chronic graft-versus-host disease. Leukemia Working Party of the European Group for Bone Marrow Transplantation. Transplant Proc. 22:1990;206-207
39. Grefte A., van der Giessen M., van Son W., The T.H. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis. 167:1993;270-277